OBI Pharma, Inc. announced the change of internal audit officer. Name, title, and resume of the previous position holder: Neo Chien/Director /Internal audit director, OBI Pharma Inc. Name, title, and resume of the new position holder: Hanna Hsu/Supervisor /Internal audit supervisor, OBI Pharma Inc. Reason for the change: Position adjustment. Effective date: November 6, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
61.2 TWD | -0.81% | -0.16% | -11.82% |
1st Jan change | Capi. | |
---|---|---|
-11.82% | 436M | |
+26.37% | 44.96B | |
-1.01% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.34% | 26.08B | |
-21.69% | 19.03B | |
+6.23% | 12.75B | |
+26.99% | 12.06B | |
-3.38% | 11.75B |
- Stock Market
- Equities
- 4174 Stock
- News OBI Pharma, Inc.
- OBI Pharma, Inc. Announces Internal Audit Officer Changes